Proteus mirabilis is a bacterium best known for causing urinary tract infections in people with indwelling catheters or structural abnormalities of the urinary tract, though it can also infect otherwise healthy individuals, particularly boys in early childhood. What sets this organism apart from the more common UTI culprit, E. coli, is its ability to produce an enzyme called urease that raises urine pH and promotes the formation of kidney and bladder stones. That combination of infection and stone formation makes P. mirabilis UTIs more complicated to treat and more prone to recurrence than a typical bladder infection.
Who Gets These Infections
P. mirabilis is primarily a pathogen of the urinary tract in people whose normal defenses have been disrupted.1PubMed Central. Proteus mirabilis and Urinary Tract Infections The single biggest risk factor is long-term catheter use. The bacterium is a leading cause of catheter-associated UTI, a category of infections that accounts for a large share of hospital-acquired infections worldwide.2PubMed Central. Initiation of swarming motility by Proteus mirabilis occurs in response to specific cues present in urine and requires excess L-glutamine Outside the catheterized population, P. mirabilis UTIs tend to show up in people with urinary tract abnormalities, such as structural malformations, kidney stones, or conditions that cause incomplete bladder emptying.3Molecular Medical Microbiology. Urinary tract infections caused by Proteus mirabilis
There is also a pediatric angle that surprises many parents. In healthy young girls, E. coli dominates as the UTI pathogen, and that is true for most demographics. But in boys after about six months of age, P. mirabilis becomes the predominant bacterium causing urinary infections. Researchers are not entirely sure why, though the anatomy of the male urinary tract and colonization patterns around the foreskin are thought to play a role.
In hospital and community urine samples, P. mirabilis accounts for a smaller share of infections than E. coli or Klebsiella, but its impact is outsized because of the complications it creates. One study of community- and hospital-acquired UTIs found P. mirabilis in about 9% of the bacterial isolates, behind E. coli and Klebsiella pneumoniae.4Gene Reports. Extended-spectrum β-lactamase variants in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis from community- and hospital-acquired urinary tract infections That may sound modest, but within the catheterized population specifically, it is one of the most frequently recovered organisms.
Symptoms of a P. Mirabilis UTI
The symptoms of a Proteus mirabilis UTI overlap substantially with those of any bacterial bladder infection: burning during urination, frequent urgent trips to the bathroom, cloudy or foul-smelling urine, and lower abdominal discomfort. In uncomplicated lower-tract infections, you would have a hard time distinguishing a P. mirabilis UTI from an E. coli one based on symptoms alone.
A few features, however, can raise suspicion. Urine infected with P. mirabilis tends to have a particularly strong, ammonia-like odor because the bacterium breaks down urea into ammonia. If the infection has progressed to the kidneys, you may develop flank pain, high fever, chills, nausea, or vomiting. Community-acquired P. mirabilis UTI with bacteremia (bacteria entering the bloodstream) has been associated with hydronephrosis, extreme temperature shifts, and elevated inflammatory markers.5PubMed. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes That scenario is serious and requires prompt treatment.
For people with catheters, symptoms look different. Catheterized patients often do not feel the typical burning or urgency. Instead, fever, new confusion in older adults, catheter blockage, or cloudy urine collecting in the drainage bag may be the first signs. The urine may also develop visible sediment or gritty crystals, a clue that the mineral-encrusting behavior unique to P. mirabilis is at work.
How P. Mirabilis Causes Infection
This organism has a toolbox of traits that make it well-adapted to life in the urinary tract, and several of those tools are unusual among common UTI bacteria.
The most distinctive is swarming motility. When P. mirabilis lands on a solid surface like a catheter, individual cells elongate dramatically, sprout dense clusters of whip-like flagella, and organize into multicellular rafts that glide rapidly across the surface.6PubMed Central. Ultrastructure of Proteus mirabilis swarmer cell rafts and role of swarming in catheter-associated urinary tract infection These swarming rafts can travel along the outside or inside of a catheter from the urethral opening up into the bladder. The swarming cells also ramp up other virulence factors at the same time, making them more aggressive than the bacterium’s non-swarming form.7Frontiers in Cellular and Infection Microbiology. Into the understanding the multicellular lifestyle of Proteus mirabilis on solid surfaces
Once in the bladder or kidneys, the bacterium uses specialized adhesive structures called fimbriae to grip the cells lining the urinary tract. P. mirabilis expresses multiple types of fimbriae, and research shows they have specific, additive roles. Knocking out two types of fimbriae at the same time reduces the organism’s ability to colonize bladders and kidneys more severely than losing either one alone.8FEMS Immunology and Medical Microbiology. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections This redundancy helps explain why the bacterium is so persistent once established.
P. mirabilis also produces a metalloprotease called ZapA that actively undermines the body’s first-line defenses. ZapA breaks down antimicrobial peptides that kidney cells secrete to kill bacteria, including human beta-defensin 1 and LL-37. Degrading these peptides significantly reduces their bacteria-killing ability, giving P. mirabilis room to multiply in tissue that would normally be hostile.9PubMed Central. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides
The Stone Problem
The complication that truly distinguishes a P. mirabilis UTI from other urinary infections is urolithiasis, the formation of urinary stones triggered by the bacterium’s urease enzyme. Urease breaks down urea in the urine and produces ammonia as a byproduct, which raises the local pH.10PubMed Central. Proteus mirabilis UreR coordinates cellular functions required for urease activity In that alkaline environment, magnesium and calcium phosphate minerals precipitate out of solution and solidify into crystals. The resulting stones are typically composed of struvite (magnesium ammonium phosphate) and carbonate apatite.11PubMed. Inhibition of crystallization caused by Proteus mirabilis during the development of infectious urolithiasis by various phenolic substances
These are often called “infection stones” or “struvite stones,” and they behave differently from the calcium oxalate stones that most people associate with kidney stones. Struvite stones can grow rapidly because the infection continuously supplies the alkaline conditions they need. They may fill an entire kidney collecting system, forming what urologists call staghorn calculi, which have a branching shape resembling a deer antler. Left untreated, progressive renal damage follows.12PubMed. Treatment options in struvite stones
For catheterized patients, the same mineral-forming process plays out on the catheter itself. P. mirabilis forms crystalline biofilms on catheter surfaces, encrusting the lumen until it partially or completely blocks urine flow.13PubMed Central. From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis Catheter blockage leads to urine retention in the bladder, which in turn promotes ascending infection toward the kidneys.14Frontiers in Cellular and Infection Microbiology. Proteus mirabilis Biofilm: Development and Therapeutic Strategies Studies of blocked catheters have confirmed that P. mirabilis biofilms are the main driver of encrustation, with layers of mineral depositing directly over living bacterial communities on the catheter surface.15PubMed. Proteus mirabilis biofilms and the encrustation of urethral catheters
The interaction between the bacterium’s fimbriae and its urease is worth noting because both are needed to start stone formation. Research has shown that clusters of P. mirabilis cells assemble in the bladder using fimbriae to stick together and urease to create the alkaline chemistry for mineralization. Eliminate either one and the stones do not form.16PubMed Central. Proteus mirabilis fimbriae- and urease-dependent clusters assemble in an extracellular niche to initiate bladder stone formation
When the Infection Reaches the Bloodstream
In severe cases, P. mirabilis can enter the blood and cause bacteremia, a potentially life-threatening event. This is relatively uncommon compared with bloodstream infections caused by other gram-negative bacteria, but it deserves attention because it carries high stakes.17PubMed Central. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases Risk factors for P. mirabilis bacteremia from a UTI include hydronephrosis (swelling of the kidney from urine backup) and community-acquired infection, which may reflect delays in diagnosis compared with hospital-monitored patients.5PubMed. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes High fever or abnormally low body temperature, along with signs of systemic inflammation, are red flags that the infection has moved beyond the urinary tract.
Diagnosis
P. mirabilis UTI is diagnosed with a standard urine culture, the same test used for any suspected UTI. A clean-catch midstream urine sample (or a sample drawn directly from the catheter port) is plated on growth media, and within a day or two the lab can identify the species and report which antibiotics work against it. P. mirabilis is easy to culture and has distinctive characteristics on agar plates, including a characteristic “swarming” growth pattern that experienced microbiologists recognize on sight.
One laboratory curiosity: P. mirabilis produces large amounts of sulfur-containing volatile compounds when grown in culture. Researchers noted decades ago that the organism generates dimethyl disulfide and methyl mercaptan from the amino acid methionine, a metabolic fingerprint distinct from E. coli.18PubMed Central. Development of specific tests for rapid detection of Escherichia coli and all species of Proteus in urine While gas chromatography is not a routine clinical tool for UTI diagnosis, that volatile chemistry is one reason P. mirabilis-infected urine has such a noticeably pungent smell.
If stones are suspected, imaging studies come into play. An ultrasound can detect hydronephrosis and larger stones, while a CT scan without contrast is the gold standard for finding smaller stones and mapping their location within the collecting system. Clinicians will also check urine pH; consistently alkaline urine in the setting of a UTI strongly suggests a urease-producing organism like P. mirabilis.
Antibiotic Treatment
Choosing the right antibiotic for a P. mirabilis UTI starts with knowing what the organism is naturally resistant to and what it remains sensitive to. P. mirabilis is intrinsically resistant to colistin and shows reduced sensitivity to imipenem compared with many other gram-negative bacteria. It is also naturally resistant to nitrofurantoin, a drug commonly prescribed for uncomplicated E. coli UTIs, which is why urine cultures matter before choosing treatment.19Frontiers in Microbiology. Genetics of Acquired Antibiotic Resistance Genes in Proteus spp.
When resistance testing is available, the picture has become more complicated in recent years. A study of P. mirabilis isolates from patients with urinary stones found that sensitivity remained high for amikacin (about 99%), meropenem (about 98%), and the combination drug cefoperazone-sulbactam (about 96%). However, sensitivity to commonly prescribed oral antibiotics was much lower: only about 58% for levofloxacin, about 51% for cefuroxime, and roughly 62% for ceftriaxone. Sulfamethoxazole performed worst, with only about a third of isolates still sensitive.20PubMed Central. Antibiotic Sensitivity of Proteus mirabilis Urinary Tract Infection in Patients with Urinary Calculi
The rising concern is the spread of extended-spectrum beta-lactamase (ESBL) producing strains. These strains carry enzymes that break down many penicillins and cephalosporins, leaving fewer oral options. Reports of multidrug-resistant P. mirabilis isolates are increasing globally.21Journal of Pure and Applied Microbiology. Antibiotic Resistance in Proteus mirabilis: Mechanism, Status, and Public Health Significance One study of clinical isolates found that all urine-derived P. mirabilis samples tested qualified as multidrug-resistant, and more than half were extensively drug-resistant.22PubMed Central. Decoding Proteus mirabilis biofilms: expression of selected virulence genes and association with antibiotic resistance Those numbers reflect a clinical research setting rather than every UTI you might encounter in a community clinic, but the trajectory is worrying.
For an uncomplicated lower-tract P. mirabilis UTI in an otherwise healthy person, a fluoroquinolone or a trimethoprim-sulfamethoxazole combination might work if sensitivity testing says so, though empiric prescribing without culture results is riskier with this organism than with E. coli because of the intrinsic and acquired resistances described above. For complicated infections involving the kidneys, stones, or bloodstream, intravenous antibiotics guided by culture results are the standard approach.
Treating the Stones, Not Just the Bacteria
Antibiotics alone are often not enough when struvite stones have formed. The stones harbor bacteria within their crystalline structure, creating a reservoir that antibiotics cannot fully penetrate. This means the infection can recur once the antibiotic course ends if the stones remain. The standard of care combines maximal surgical stone removal with culture-specific antibiotics and sometimes urease inhibitors. That multimodal approach is synergistic: surgery removes the bulk of the infected mineral, and antibiotics mop up the remaining bacteria.12PubMed. Treatment options in struvite stones
Shock wave lithotripsy (a non-invasive procedure that uses focused sound waves to break stones into fragments) can effectively pulverize struvite stones, but tiny residual fragments may linger in the kidney for months, continuing to harbor P. mirabilis. A study of women treated with shock wave lithotripsy for P. mirabilis struvite stones found that these residual fragments could often be sterilized with a course of antibiotics, in contrast to intact stones, which resist sterilization.23The Journal of Urology. Bacteriuria Following Extracorporeal Shock Wave Lithotripsy of Infection Stones The takeaway is that reducing stone burden to small fragments opens the door for antibiotics to finish the job, but skipping stone removal entirely is a recipe for relapse.
Prevention in Catheterized Patients
Because catheter-associated UTI is the bread and butter of P. mirabilis infections, prevention strategies focus heavily on catheter management. The simplest and most effective measure is minimizing how long a catheter stays in place. Every additional day of catheterization increases the risk of bacterial colonization. When a catheter must remain, routine care includes maintaining a closed drainage system, keeping the collection bag below bladder level, and ensuring adequate fluid intake.
The problem of catheter encrustation has prompted research into dietary and pharmacological approaches. Supplementing daily fluid intake with citrate-containing beverages (such as certain fruit juices) may help by lowering urinary pH and making it harder for struvite crystals to form. A review of encrustation prevention strategies found that promoting an acidic urinary pH through citrate supplementation was one of the simplest, least expensive, and most broadly applicable interventions available.24International Journal of Urological Nursing. Encrustations of the urinary catheter and prevention strategies: a literature review Silver-coated or antibiotic-impregnated catheters have been tested as well, with mixed evidence on long-term benefit.
For patients who experience repeated catheter blockages from P. mirabilis, some clinicians schedule prophylactic catheter changes at intervals shorter than the blockage cycle, essentially replacing the catheter before it has time to become fully encrusted. This is a practical workaround rather than a cure, but it can reduce emergency visits and episodes of urine retention.
Phage Therapy and Other Experimental Approaches
The rising tide of antibiotic resistance has pushed researchers to look beyond conventional drugs. One area gaining traction for P. mirabilis specifically is bacteriophage therapy, the use of viruses that infect and kill bacteria. Phages are highly specific, meaning a cocktail designed against P. mirabilis will not disturb the rest of the body’s microbial community the way a broad-spectrum antibiotic would.
Laboratory and animal studies have produced encouraging results. A cocktail of two lytic phages tested in a phantom bladder model (a lab simulation of catheter conditions) reduced P. mirabilis biofilm mass by about 65% and downregulated genes involved in biofilm formation.25PubMed Central. A Phage Cocktail To Control Surface Colonization by Proteus mirabilis in Catheter-Associated Urinary Tract Infections A more recent mouse study combined the same two phages with a plant extract and achieved a dramatic reduction in bacterial counts in both kidneys and bladders, with the combination outperforming either treatment alone.26PubMed Central. A Novel Therapeutic Approach: Phage and Alhagi maurorum Synergy Against Kidney and Bladder Infection Caused by Proteus mirabilis in BALB/c Mice
Phage therapy for UTIs is still experimental, and translating lab results to hospital bedside involves big unknowns around dosing, delivery route, and whether phage-resistant bacterial mutants emerge quickly. But the work is further along for catheter-associated P. mirabilis infections than for many other targets, partly because the catheter itself is a convenient surface to coat with phage preparations. If resistance to front-line antibiotics keeps climbing, phage therapy could become a real clinical option within the next decade rather than a perpetually “promising” curiosity.
Why P. Mirabilis Infections Tend to Recur
Recurrence is the central frustration for patients and clinicians dealing with P. mirabilis UTIs. The reasons tie back to the biology described above. Struvite stones shelter bacteria from antibiotics, so even a course that clears the urine can leave a reservoir inside the stone. Biofilms on catheters serve the same role, protecting embedded bacteria from both antibiotics and the immune system. And the organism’s multiple types of fimbriae give it redundant attachment strategies; even if the immune system or a drug knocks out one adhesion pathway, another can keep the infection going.27PubMed. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection
The practical lesson is that managing a P. mirabilis UTI is rarely a one-and-done affair. Effective treatment usually requires addressing the underlying risk factor (removing or replacing the catheter, surgically reducing stone burden, correcting a structural abnormality) alongside antibiotic therapy guided by culture results. Patients who continue to have catheter blockage or recurrent positive cultures after standard treatment should be evaluated for retained stone fragments or an alternative source of infection.